Risk factors for major cardiovascular adverse events and the effects of sacubitril/valsartan in patients with acute myocardial infarction after Percutaneous Coronary Intervention
Use of SV can improve blood lipids, hemorheology, and cardiac function, and reduce the incidence of post-PCI MACEs in these patients.
Authors
- Yuxiang Wen
- Yang Peng (ORCID: https://orcid.org/0000-0003-4901-2662)
- Wei Han (ORCID: https://orcid.org/0000-0001-5628-3036)
Institutions
- Yangtze University (CN)
Publication Details
- Journal
- Pakistan Journal of Medical Sciences
- Published
- 2025-06-02
- DOI
- https://doi.org/10.12669/pjms.41.6.10819
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00